Lansing Street Advisors’s Zimmer Biomet ZBH Stock Holding History

Lansing Street Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$437	Buy	+3	New	+$408	﹤0.01%	264

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Lansing Street Advisors's ZBH Position: Q2 2023 in Review

Lansing Street Advisors opened a new position in Zimmer Biomet (ZBH) in Q2 2023: 3 shares worth $437. The stake represents ﹤0.01% of the portfolio and ranks #264 among its holdings.

1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

Lansing Street Advisors held 3 shares of Zimmer Biomet worth $437 as of Q2 2023.
Zimmer Biomet was a new Lansing Street Advisors position in Q2 2023.
Zimmer Biomet made up ﹤0.01% of Lansing Street Advisors's portfolio in Q2 2023, its #264 holding.
1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Lansing Street Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.